IL6 and breast carcinoma: Despite the presence of differences in subpopulations, the majority of these cells produce interleukin 6 (IL-6), a key factor in the development of immune resistance in breast cancer (BC) patients [32] and the promotion of thyroid cancer (TC) cell proliferation [33].